A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
      Google Scholar   
Citation:
N Engl J Med vol 348 (10) 883-90
Year:
2003
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
CA02599, CA03927, CA04326, CA04457, CA07968, CA08025, CA11789, CA12046, CA12449, CA16450, CA21060, CA25224, CA31946, CA31983, CA32291, CA33601, CA35091, CA35279, CA35421, CA37135, CA41287, CA45389, CA45418, CA45564, CA45808, CA47555, CA47559, CA47577, CA47642, CA52784, CA67663, CA74811, CA77298, CA77406, CA77440, CA77658, DK 34987, RR00046  
Corr. Author:
 
Authors:
                         
Networks:
 
Study
CALGB-9270
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Adenoma, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Colonic Polyps, Colonoscopy, Colorectal Neoplasms, Disease-Free Survival, Double-Blind Method, Female, Humans, Male, Middle Aged, Multivariate Analysis, Risk, Secondary Prevention